Zacks: Brokerages Anticipate Moderna Inc (NASDAQ) (MRNA) Will Announce Earnings of -$0.41 Per Share

Share on StockTwits

Wall Street analysts forecast that Moderna Inc (NASDAQ) (NYSE:MRNA) will announce earnings of ($0.41) per share for the current quarter, according to Zacks. Three analysts have made estimates for Moderna Inc (NASDAQ)’s earnings, with the highest EPS estimate coming in at ($0.25) and the lowest estimate coming in at ($0.50). The firm is expected to announce its next earnings report on Thursday, August 8th.

Zacks’ EPS calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Moderna Inc (NASDAQ).

Moderna Inc (NASDAQ) (NYSE:MRNA) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by ($0.05). The firm had revenue of $16.03 million for the quarter, compared to the consensus estimate of $33.59 million.

Separately, Chardan Capital reissued a “buy” rating on shares of Moderna Inc (NASDAQ) in a report on Sunday, April 7th.

Shares of MRNA stock traded down $0.71 on Friday, hitting $20.78. The stock had a trading volume of 443,509 shares, compared to its average volume of 920,813. Moderna Inc has a twelve month low of $13.03 and a twelve month high of $29.79.

Moderna Inc (NASDAQ) Company Profile

Moderna, Inc, a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. As of February 15, 2019 the company had 11 programs in clinical trials and a total of 20 development candidates in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.

Recommended Story: What is the Beige Book?

Get a free copy of the Zacks research report on Moderna Inc (NASDAQ) (MRNA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Moderna Inc (NASDAQ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moderna Inc (NASDAQ) and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Analysts Expect Bank of Hawaii Co.  to Announce $1.38 Earnings Per Share
Analysts Expect Bank of Hawaii Co. to Announce $1.38 Earnings Per Share
Soarcoin 1-Day Trading Volume Tops $220.00
Soarcoin 1-Day Trading Volume Tops $220.00
Mason Graphite  Shares Up 5.6%
Mason Graphite Shares Up 5.6%
Continental Gold  Shares Up 0.7%
Continental Gold Shares Up 0.7%
Arcus Biosciences Inc  Short Interest Update
Arcus Biosciences Inc Short Interest Update
Hancock Whitney Corp  Given Average Rating of “Buy” by Analysts
Hancock Whitney Corp Given Average Rating of “Buy” by Analysts


 
© 2006-2019 Zolmax.